Alnylam Pharmaceuticals
ALNY
#430
Rank
S$70.36 B
Marketcap
S$532.61
Share price
2.02%
Change (1 day)
56.05%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company